5911 studies found for:    INS
Show Display Options
Rank Status Study
1 Terminated Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and Adolescents
Condition: Diabetes Type 1
Interventions: Drug: insulin Glargine + Insulin Apidra;   Drug: Insulin NPH + Insulin Apidra: Active Comparator
2 Completed Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Long-acting bedtime insulin detemir (Levemir);   Drug: Insulin detemir and pre-meal insulin aspart.
3 Enrolling by invitation Comparison Study of Insulin Glargine and NPH Insulin
Condition: Diabetes
Interventions: Drug: Switching to NPH insulin;   Drug: Continuation of insulin glargine
4 Completed U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod
Conditions: Type 2 Diabetes;   Insulin Resistance
Intervention: Drug: U-500 Insulin delivered by Omnipod (disposable insulin pump)
5 Completed
Has Results
Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: biphasic insulin aspart;   Drug: insulin detemir;   Drug: insulin aspart
6 Completed Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NPH;   Drug: Detemir;   Drug: Glargine
7 Terminated Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine
Conditions: Diabetes;   Obesity
Interventions: Drug: insulin Levemir;   Drug: insulin Lantus
8 Completed
Has Results
Comparison of Insulins Aspart and Lispro in Insulin Pumps
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Insulin Aspart;   Drug: Insulin Lispro
9 Completed
Has Results
Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Insulin glulisine;   Drug: Insulin lispro;   Drug: Insulin aspart
10 Completed Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin Lispro;   Drug: Insulin Aspart
11 Completed Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
Condition: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: Drug: Detemir + aspart insulin before meals;   Drug: NPH insulin + regular insulin
12 Unknown  Insulin Exposure and Glucose Response to Meals in Type 1 Diabetic Subjects Administered Two Different Insulin Regimens Compared to the Endogenous Insulin Exposure and Glucose Response to Meals In Healthy Adult Controls
Condition: Type 1 Diabetes
Interventions: Drug: Insulin glulisine;   Drug: Insulin
13 Completed Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glulisine;   Drug: Insulin aspart
14 Completed A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human Insulin
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Insulin Aspart, BIAsp 70, BIAsp50, Human Insulin
15 Completed Pharmacokinetic and Glucodynamic Crossover Study of SC Administered Insulin Lispro +rHuPH20 and Regular Human Insulin +rHuPH20 Compared to Insulin Lispro Alone
Condition: Healthy Volunteers
Intervention: Drug: Lispro, Regular Human Insulin, rHuPH20
16 Completed
Has Results
Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: insulin detemir;   Drug: NPH insulin;   Drug: insulin aspart
17 Completed
Has Results
Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Insulin lispro 2 day reservoir in-use;   Drug: Insulin lispro 6 day reservoir in-use;   Drug: Insulin aspart 6 day reservoir in-use
18 Recruiting The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism
Condition: Diabetes
Interventions: Drug: central insulin;   Drug: Placebo
19 Unknown  Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: insulin aspart and detemir (NovoRapid, Levemir);   Drug: human regular insulin and NPH insulin (Actrapid, Protaphne)
20 Completed A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro
Condition: Diabetes Mellitus
Interventions: Drug: Regular Human Insulin;   Drug: Lispro;   Drug: VIAject;   Drug: VIAject 50%;   Drug: VIAject/Insulin Glargine;   Drug: Insulin Glargine/VIAject

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years